We are live on ! Find out more
CP

Centerbridge Partners Portfolio holdings

AUM $61.1M
1-Year Est. Return 3.67%
This Fund
S&P 500
This Quarter Est. Return
-16.88%
1 Year Est. Return
+3.67%
3 Year Est. Return
+16.09%
5 Year Est. Return
+20.97%
10 Year Est. Return
+25.5%
AUM
$875M
AUM Growth
-$255M
Cap. Flow
-$66.2M
Cap. Flow %
-7.56%
Top 10 Hldgs %
99.65%
Holding
37
New
1
Increased
–
Reduced
1
Closed
4

Top Buys

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$2.95M

Top Sells

Rank Stock Value
1
GNK icon
Genco Shipping & Trading
GNK
+$29.7M
2
VTIQ
VectoIQ Acquisition Corp. II Class A Common Stock
VTIQ
+$19.1M
3
CYH icon
Community Health Systems
CYH
+$3.52M
4
AGCB
Altimeter Growth Corp 2
AGCB
+$1.48M
5
DRTSW icon
Alpha Tau Medical Warrant
DRTSW
+$24K

Sector Composition

Rank Sector Weight
1 Real Estate 20.81%
2 Consumer Discretionary 16.13%
3 Industrials 3.86%
4 Financials 1.65%
5 Technology 0.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HIIIW
26
DELISTED
Hudson Executive Investment Corp. III Warrant
HIIIW
$2K ﹤0.01%
19,999
– –
IIIIW
27
DELISTED
INSU Acquisition Corp. III Warrant
IIIIW
$2K ﹤0.01%
33,333
– –
COLIW
28
DELISTED
Colicity Inc. Warrant
COLIW
$2K ﹤0.01%
19,999
– –
RXRAW
29
DELISTED
RXR Acquisition Corp. Warrants to purchase Class A common stock
RXRAW
$2K ﹤0.01%
19,999
– –
FACA.WS
30
DELISTED
Figure Acquisition Corp. I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
FACA.WS
$2K ﹤0.01%
24,999
– –
SHACW
31
DELISTED
SCP & CO Healthcare Acquisition Company Warrant
SHACW
$2K ﹤0.01%
50,000
– –
CPTK.WS
32
DELISTED
Crown PropTech Acquisitions Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CPTK.WS
$2K ﹤0.01%
33,333
– –
CYH icon
33
Community Health Systems
CYH
$440M
– –
-939,903
Closed -$3.52M
DRTSW icon
34
Alpha Tau Medical Warrant
DRTSW
$88M
– –
-50,000
Closed -$24K
AGCB
35
DELISTED
Altimeter Growth Corp 2
AGCB
– –
-150,000
Closed -$1.48M
VTIQ
36
DELISTED
VectoIQ Acquisition Corp. II Class A Common Stock
VTIQ
– –
-1,950,000
Closed -$19.1M
1
2

Similar funds

NJBEST
New Jersey Better Educational Savings Trust Trenton, New Jersey $60.9M AUM 2.64% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
HPCM
Hein Park Capital Management New York $61.3M AUM 14.47% 1-Year Est. Return
TCM
Tuttle Capital Management Riverside, Connecticut $60.8M AUM 17.47% 1-Year Est. Return
TCDRS
Texas County & District Retirement System Austin, Texas $60.8M AUM 29.03% 1-Year Est. Return
ACM
AREX Capital Management New York $60.5M AUM 45.91% 1-Year Est. Return
CMANY
Capital Management Associates (New York) New York $60.2M AUM 58.47% 1-Year Est. Return
NI
NCP Inc La Quinta, California $60.1M AUM 39.78% 1-Year Est. Return

Centerbridge Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Centerbridge Partners held 37 positions worth $875M, down 23% from $1.13B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Centerbridge Partners withdrew a net $66.2M in Q3 2022, closing 4 positions and reducing 1 holding. Its most notable exit was VectoIQ Acquisition Corp. II Class A Common Stock, an estimated $19.1M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 21% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Centerbridge Partners opened a new position in Bausch Health worth $2.93M.

  • Centerbridge Partners's largest Q3 2022 buy was Bausch Health: 425,000 shares worth $2.93M.
  • Centerbridge Partners's biggest Q3 2022 reduction was Genco Shipping & Trading, cutting an estimated $29.7M.
  • Centerbridge Partners fully exited VectoIQ Acquisition Corp. II Class A Common Stock in Q3 2022, selling an estimated $19.1M.
  • Centerbridge Partners's ten largest holdings make up 100% of its $875M portfolio in Q3 2022.
  • Centerbridge Partners opened 1 new position and closed 4 in Q3 2022.
  • Centerbridge Partners's portfolio value fell 23% quarter-over-quarter to $875M.

Based on Centerbridge Partners's 13F filing for Q3 2022, filed 14 Nov 2022.